(Q51830023)

13 April 2018

title

Cost-effectiveness of infant vaccination with RIX4414 (Rotarix) in the UK. (English)

1 reference

13 April 2018

author name string

A Martin

1

1 reference

13 April 2018

A Batty

2

1 reference

13 April 2018

J A Roberts

3

1 reference

13 April 2018

B Standaert

4

1 reference

13 April 2018

language of work or name

English

0 references

publication date

27 May 2009

1 reference

13 April 2018

published in

Vaccine

1 reference

13 April 2018

volume

27

1 reference

13 April 2018

issue

33

1 reference

13 April 2018

page(s)

4520-4528

1 reference

13 April 2018

Global Illness and Deaths Caused by Rotavirus Disease in Children

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Rotavirus and severe childhood diarrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Evaluating rotavirus vaccination in England and Wales. Part I. Estimating the burden of disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Nosocomial rotavirus infections: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe: executive summary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Economics notes: Converting international cost effectiveness data to UK prices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Exploring the cost effectiveness of an immunization programme for rotavirus gastroenteritis in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Detection by PCR of eight groups of enteric pathogens in 4,627 faecal samples: re-examination of the English case-control Infectious Intestinal Disease Study (1993-1996).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

[Morbidity and cost of rotavirus infections in France]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Acute gastro-enteritis in children in France: estimates of disease burden through national hospital discharge data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

[Evaluation of the ambulatory treatment of acute diarrhea in infants. Réseau interhospitalier d'evaluation des pratigues médicales dans les affections courantes de l'enfant]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Rotavirus infection in infants as protection against subsequent infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance. The Infectious Intestinal Disease Study Executive

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Hospital admissions attributable to rotavirus infection in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Impact of rotavirus infection on a paediatric hospital in the east end of London

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Healthcare-associated rotavirus gastroenteritis in a large paediatric hospital in the UK

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Estimating the number of deaths with rotavirus as a cause in England and wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

What can analysis of calls to NHS direct tell us about the epidemiology of gastrointestinal infections in the community?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Estimating utility scores in young children with acute rotavirus gastroenteritis in the UK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Economic evaluation of an acute paediatric hospital at home clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Costs of community-acquired pediatric rotavirus gastroenteritis in 7 European countries: the REVEAL Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

The study of infectious intestinal disease in England: socio-economic impact

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Economic evaluation of human papillomavirus vaccination in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

An estimate of the proportion of diarrhoeal disease episodes seen by general practitioners attributable to rotavirus in children under 5 y of age in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Clinical consequences of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Cost and cost-effectiveness of childhood vaccination against rotavirus in France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care'' disease impact in Belgium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

Cost-effectiveness and potential impact of rotavirus vaccination in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.006

10.1016/J.VACCINE.2009.05.006

7 January 2021

Identifiers

DOI

1 reference

13 April 2018

1 reference

13 April 2018